LEP and cancer: Leptin exhibits potent oncogenic actions and acts on different stages of cancer, including cell proliferation, angiogenesis, metastasis, and drug resistance, via multiple mechanisms such as activation of MEK/ERK1/2 and PI3K/Akt signaling pathways, autophagy induction, and NLRP3 inflammasome activation [3, 4, 5, 6].